Biolution GmbH

Biolution GmbH is an SME in Wien, Austria that has taken part in 12 EU-funded projects since 2008, receiving €2.3M in EU funding and leading 1 as coordinator.

EU funding received€2.3M
EU projects12
As coordinator1
Running now2
First EU project2008
Latest project2024
CountryAustria
EU registration (PIC)999680449
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biolution GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.9M · 8 projects
  • Horizon 2020€376k · 2 projects
  • Horizon Europe€0 · 2 projects

Projects

12 EU-funded projects, newest first. Biolution GmbH led 1 of them as coordinator. Each links to the official record.

  • eRaDicateAssociated partner

    Innovative ligands for nuclear receptors to eradicate cancer relapse.

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • FANTOMAssociated partner

    Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • ALKATRASPartner

    ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

  • EUthyroidPartner

    Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €376ktheir share
  • SYSVASCPartner

    Systems Biology to Identify Molecular Targets for Vascular Disease Treatment

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €76ktheir share
  • SYMPATHPartner

    Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €685ktheir share
  • EARLYNUTRITIONPartner

    Long-term effects of early nutrition on later health

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €97ktheir share
  • DEVELAGEPartner

    Pathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €268ktheir share
  • VBC ERNPartner

    Vienna Biocenter European Researchers Night

    FP7 (2007 to 2013) · 2009–2009 · Project on CORDIS ↗

    €37ktheir share
  • PORCoordinator

    Disseminate the Power Of Research through an on-line simulation of the scientific endeavour

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €201ktheir share
  • TOBIPartner

    Targeting OBesity-driven Inflammation

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €284ktheir share
  • GENINCAPartner

    Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €267ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alzheimer
  • cardiovascular diseases
  • cells technologies
  • colorectal cancer
  • databases
  • drug discovery
  • endocrinology
  • energy and fuels
  • epigenetics
  • genomes
  • halogens
  • immunology
  • liver cancer
  • neurobiology

Biolution GmbH is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime